The VIFs for APOE ε4 and its interaction with AD concerns exceeded 5, so we computed separate regressions for carriers and non‐carriers; higher CADQ scores were significantly positively associated with likelihood of daily guidelines in APOE ε4 non‐carriers (p = 0.024), but not in carriers (p = 0.778). Here, APOE is linked to Alzheimer disease.